Comment from anonymous

Document ID: CDC-2012-0003-0002
Document Type: Public Submission
Agency: Centers For Disease Control And Prevention
Received Date: April 10 2012, at 12:00 AM Eastern Daylight Time
Date Posted: April 11 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: February 10 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: April 10 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fed2a2
View Document:  View as format xml

View Comment

Establishing user fees for filovirus testing of nonhuman primate liver samples seems like a necessary step toward protecting our biological well being. This country should do all it can to protect its citizens from extremely debilitating viruses like the ebola virus. The fact that the only private testing service is no longer providing its service shows why this proposal is essential. The testing has been determined to be necessary for safety concerns. Logistical and monetary concerns regarding the continuance of this program should not come into question when safety is at stake. One potential issue that could become costly is the storing of the records. Because this service is now going to be provided by the government through user fees, there may be potential for further increases in user donations. Issues like data storage and further growth could cause financial concern to some of users of the service. Again, the purpose of this regulation far outweighs any other concerns regarding testing nonhuman primates for filoviruses when they die from causes other than trauma. The people willing to subject the masses to certain risks affiliated with nonhuman primates should be willing to absorb the preventative costs toward containing any potential outbreaks. No one knows when the ebola virus will change and potentially become airborne, and the utmost protections ought to be taken to prevent such a scenario. I support this regulation 100%.

Related Comments

   
Total: 1
Comment from anonymous
Public Submission    Posted: 04/11/2012     ID: CDC-2012-0003-0002

Apr 10,2012 11:59 PM ET